KATRINA SELSOR: Open Payments
NPI 1073020673 · SPARTA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 41 payments from 15 companies in 2025. Trend: 2023 $1,370 · 2024 $1,145 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $202 |
| ABBVIE INC. | 11 | $170 |
| Globus Medical, Inc. | 2 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Lundbeck LLC | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Lilly USA, LLC | 2 | $40 |
| PFIZER INC. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: REXULTI, AIRSUPRA, VRAYLAR, Senza, CAPLYTA, FARXIGA, UBRELVY, MOUNJARO.
Industry payments across MO — which companies pay providers there.
